BMI1 and glioblastoma: Significant differences were observed in the relative expression of Bmi-1 (Fig 2A) and CCND1 (Fig 2C) between grades II and IV astrocytomas (p<0.001 for both), with a 1.15-fold and 1.31-fold increase in their expression in GBM samples, respectively.